scroll to top.svgleft arrow.svgright arrow-1.svg
AAAAI logo.svg
share_on_x_twitter.svgShare on Facebook.svgshare on Linkedin.svg

Board of Directors February Meeting Highlights

The AAAAI Board of Directors met in late February, in San Antonio, Texas. The members of the Board of Directors appreciate the work of AAAAI committee members and chairs as they strive toward the AAAAI mission to advance the knowledge and practice of allergy, asthma and immunology for optimal patient care. Board members also heard reports from the Chair of the Annual Meeting Program Committee (AMPC), and Editors-in-Chief of JACI, JACI: In Practice and JACI: Global.
Over the course of the meeting, a number of significant decisions and actions were made. Here are the highlights:
A number of requests were granted approval, including the continuation and expansion of the Chrysalis Project as well as additional funding for travel scholarships, which you can learn more about here. The Board also approved a Discovery Program at the 2024 Annual Meeting for basic and translational science.
Additionally, the AAAAI Foundation was granted approval for the continuation of the Faculty Development Awards, including an increase in funding from $240,000 to $300,000 per 3-year award.
Presidential Presentations
David A. Khan, MD, FAAAAI, shared updates on his presidential initiatives including:
  • Fei Li Kuang, MD, PhD, was approved as the 2023 AAAAI Drug Hypersensitivity Research Grant awardee for her project on patients with DRESS syndrome.
  • The Prior Authorization Task Force finished the AAAAI position statement on Prior Authorization with publication in JACI: In Practice, and continues to work on the development of a Work Group Report on the impact of prior authorizations on patient care. Learn more in our feature story, here.
  • The Regional Outreach on Allergy/Immunology for Residents (ROAR) planning group is encouraged by the continued positive feedback on ROAR. Dr. Khan, along with ROAR Chairs and RSL representatives, will meet to discuss possible next steps for continuation of the program following the final session in the series, which took place in March 2023.
Jonathan A. Bernstein, MD, FAAAAI, provided additional insights into his coming presidential initiatives, including a deeper look at his plan for incorporating volunteerism into the AAAAI landscape. To learn more about these initiatives, tune into Conversations from the World of Allergy podcast, Episode 88: “A Focus on the Environment and Community: New Presidential Initiatives”
The leadership of AAAAI met with leaders of the ABAI, ACAAI, EAACI and WAO to continue discussions on current and future collaboration on projects and initiatives, including the ABAI Continuous Assessment Program, the Joint Task Force on Practice Parameters, planned consensus statements and additional meetings.
A number of other projects and topics were discussed, including next steps for the AAAAI Registry and work with AAFA to support the Breathe 4 Baby program.
In addition, the three divisions of the Board of Directors—Education, Practice & Policy and Research & Training—met individually to discuss committee activities.
The next Board of Directors meeting
June 16-18, 2023
Cincinnati, OH